Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Gastric Motility Disorder Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Concert Pharmaceuticals, Inc
Targacept, Inc
ChironWells GmbH
Helsinn Healthcare SA
Theravance, Inc
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Velusetrag
Ipamorelin
TD-8954
Others
Application:
Hospital
Clinic
Home Use
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Gastric Motility Disorder Drug Industry Overview
-
1.1.1 Gastric Motility Disorder Drug Market Scope and Market Segments
-
1.1.2 Gastric Motility Disorder Drug Industry Characteristics
-
1.1.3 Global and China Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Gastric Motility Disorder Drug Production Value and Growth Rate (2017-2028)
-
1.2 Global Gastric Motility Disorder Drug Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Velusetrag
-
1.2.2 Ipamorelin
-
1.2.3 TD-8954
-
1.2.4 Others
-
1.3 Global Gastric Motility Disorder Drug Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital
-
1.3.2 Clinic
-
1.3.3 Home Use
-
1.4 Market Analysis by Region
-
1.4.1 North America Gastric Motility Disorder Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Gastric Motility Disorder Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Gastric Motility Disorder Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Gastric Motility Disorder Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Gastric Motility Disorder Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Gastric Motility Disorder Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Gastric Motility Disorder Drug Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Gastric Motility Disorder Drug Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Gastric Motility Disorder Drug Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Gastric Motility Disorder Drug Industry Porter's Five Forces Model Analysis
-
2.2.3 Gastric Motility Disorder Drug Industry PEST Analysis
-
2.3 Gastric Motility Disorder Drug Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Gastric Motility Disorder Drug Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Gastric Motility Disorder Drug Industry
Chapter 3 Global and China Gastric Motility Disorder Drug Market, by Manufacturer
-
3.1 Global and China Gastric Motility Disorder Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Gastric Motility Disorder Drug Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Gastric Motility Disorder Drug Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Gastric Motility Disorder Drug Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Gastric Motility Disorder Drug Market Top 3 Players
Chapter 4 Global and China Gastric Motility Disorder Drug Market, by Type (2017-2028)
-
4.1 Gastric Motility Disorder Drug Market Trend, by Type
-
4.2 Global Gastric Motility Disorder Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Gastric Motility Disorder Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Gastric Motility Disorder Drug Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Gastric Motility Disorder Drug Price Trend, by Type (2017-2028)
-
4.3 China Gastric Motility Disorder Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Gastric Motility Disorder Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Gastric Motility Disorder Drug Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Gastric Motility Disorder Drug Price Trend, by Type (2017-2028)
Chapter 5 Global and China Gastric Motility Disorder Drug Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Gastric Motility Disorder Drug Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Gastric Motility Disorder Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Gastric Motility Disorder Drug Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Gastric Motility Disorder Drug Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Gastric Motility Disorder Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Gastric Motility Disorder Drug Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Gastric Motility Disorder Drug Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Gastric Motility Disorder Drug Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Gastric Motility Disorder Drug Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Gastric Motility Disorder Drug Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Gastric Motility Disorder Drug Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Gastric Motility Disorder Drug Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Gastric Motility Disorder Drug Market Analysis
-
7.1 North America Gastric Motility Disorder Drug Market, by Type
-
7.2 North America Gastric Motility Disorder Drug Market, by Application
-
7.3 North America Gastric Motility Disorder Drug Market Analysis and Forecast, by Country
-
7.3.1 United States Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Gastric Motility Disorder Drug Market Analysis
-
8.1 Europe Gastric Motility Disorder Drug Market, by Type
-
8.2 Europe Gastric Motility Disorder Drug Market, by Application
-
8.3 Europe Gastric Motility Disorder Drug Market Analysis and Forecast, by Country
-
8.3.1 Germany Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Gastric Motility Disorder Drug Market Analysis
-
9.1 APAC Gastric Motility Disorder Drug Market, by Type
-
9.2 APAC Gastric Motility Disorder Drug Market, by Application
-
9.3 APAC Gastric Motility Disorder Drug Market Analysis and Forecast, by Country
-
9.3.1 China Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Gastric Motility Disorder Drug Market Analysis
-
10.1 Latin America, Middle East and Africa Gastric Motility Disorder Drug Market, by Type
-
10.2 Latin America, Middle East and Africa Gastric Motility Disorder Drug Market, by Application
-
10.3 Latin America, Middle East and Africa Gastric Motility Disorder Drug Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Gastric Motility Disorder Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Gastric Motility Disorder Drug Company Profiles
-
11.1 Concert Pharmaceuticals, Inc
-
11.1.1 Concert Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Concert Pharmaceuticals, Inc Gastric Motility Disorder Drug Product Profiles, Application and Specification
-
11.1.3 Concert Pharmaceuticals, Inc Gastric Motility Disorder Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Targacept, Inc
-
11.2.1 Targacept, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Targacept, Inc Gastric Motility Disorder Drug Product Profiles, Application and Specification
-
11.2.3 Targacept, Inc Gastric Motility Disorder Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 ChironWells GmbH
-
11.3.1 ChironWells GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 ChironWells GmbH Gastric Motility Disorder Drug Product Profiles, Application and Specification
-
11.3.3 ChironWells GmbH Gastric Motility Disorder Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Helsinn Healthcare SA
-
11.4.1 Helsinn Healthcare SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Helsinn Healthcare SA Gastric Motility Disorder Drug Product Profiles, Application and Specification
-
11.4.3 Helsinn Healthcare SA Gastric Motility Disorder Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Theravance, Inc
-
11.5.1 Theravance, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Theravance, Inc Gastric Motility Disorder Drug Product Profiles, Application and Specification
-
11.5.3 Theravance, Inc Gastric Motility Disorder Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Gastric Motility Disorder Drug Industry Investment Prospect and Risk Assessment
-
12.1 Gastric Motility Disorder Drug Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Gastric Motility Disorder Drug Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Global Gastric Motility Disorder Drug Production Value and Growth Rate (2017-2028)
-
Figure China Gastric Motility Disorder Drug Production Value and Growth Rate (2017-2028)
-
Figure Global Gastric Motility Disorder Drug Market Size and Growth Rate of Velusetrag (2017-2028)
-
Figure Global Gastric Motility Disorder Drug Market Size and Growth Rate of Ipamorelin (2017-2028)
-
Figure Global Gastric Motility Disorder Drug Market Size and Growth Rate of TD-8954 (2017-2028)
-
Figure Global Gastric Motility Disorder Drug Market Size and Growth Rate of Others (2017-2028)
-
Figure Global Gastric Motility Disorder Drug Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Gastric Motility Disorder Drug Market Size and Growth Rate of Clinic (2017-2028)
-
Figure Global Gastric Motility Disorder Drug Market Size and Growth Rate of Home Use (2017-2028)
-
Figure North America Gastric Motility Disorder Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Gastric Motility Disorder Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Gastric Motility Disorder Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Gastric Motility Disorder Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Gastric Motility Disorder Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Gastric Motility Disorder Drug Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Gastric Motility Disorder Drug Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Gastric Motility Disorder Drug Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Gastric Motility Disorder Drug Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Gastric Motility Disorder Drug Market Share, by Manufacturer in 2021
-
Figure Global and China Gastric Motility Disorder Drug Market Share, by Manufacturer in 2022
-
Table Global Gastric Motility Disorder Drug Sales Volume, by Type (2017-2028)
-
Table Global Gastric Motility Disorder Drug Sales Volume Share, by Type (2017-2028)
-
Figure Global Gastric Motility Disorder Drug Sales Volume Share, by Type (2017-2028)
-
Table Global Gastric Motility Disorder Drug Sales Value, by Type (2017-2028)
-
Table Global Gastric Motility Disorder Drug Sales Value Share, by Type (2017-2028)
-
Figure Global Gastric Motility Disorder Drug Price Trend, by Type (2017-2028)
-
Table China Gastric Motility Disorder Drug Sales Volume, by Type (2017-2028)
-
Table China Gastric Motility Disorder Drug Sales Volume Share, by Type (2017-2028)
-
Figure China Gastric Motility Disorder Drug Sales Volume Share, by Type (2017-2028)
-
Table China Gastric Motility Disorder Drug Sales Value, by Type (2017-2028)
-
Table China Gastric Motility Disorder Drug Sales Value Share, by Type (2017-2028)
-
Figure China Gastric Motility Disorder Drug Price Trend, by Type (2017-2028)
-
Table Global Gastric Motility Disorder Drug Sales Volume, by Application (2017-2028)
-
Table Global Gastric Motility Disorder Drug Sales Volume Share, by Application (2017-2028)
-
Figure Global Gastric Motility Disorder Drug Sales Volume Share, by Application (2017-2028)
-
Table Global Gastric Motility Disorder Drug Sales Value, by Application (2017-2028)
-
Table Global Gastric Motility Disorder Drug Sales Value Share, by Application (2017-2028)
-
Figure Global Gastric Motility Disorder Drug Sales Value Share, by Application (2017-2028)
-
Table China Gastric Motility Disorder Drug Sales Volume, by Application (2017-2028)
-
Table China Gastric Motility Disorder Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Gastric Motility Disorder Drug Sales Volume Share, by Application (2017-2028)
-
Table China Gastric Motility Disorder Drug Sales Value, by Application (2017-2028)
-
Table China Gastric Motility Disorder Drug Sales Value Share, by Application (2017-2028)
-
Figure China Gastric Motility Disorder Drug Sales Value Share, by Application (2017-2028)
-
Figure China Gastric Motility Disorder Drug Production, Import, Consumption and Export (2017-2022)
-
Figure North America Gastric Motility Disorder Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Gastric Motility Disorder Drug Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Gastric Motility Disorder Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Gastric Motility Disorder Drug Production, Import, Consumption and Export (2017-2022)
-
Table North America Gastric Motility Disorder Drug Sales Volume, by Type (2017-2028)
-
Table North America Gastric Motility Disorder Drug Sales Volume Share, by Type (2017-2028)
-
Figure North America Gastric Motility Disorder Drug Sales Volume Share, by Type (2017-2028)
-
Table North America Gastric Motility Disorder Drug Sales Volume, by Application (2017-2028)
-
Table North America Gastric Motility Disorder Drug Sales Volume Share, by Application (2017-2028)
-
Figure North America Gastric Motility Disorder Drug Sales Volume Share, by Application (2017-2028)
-
Figure United States Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure United States Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure Canada Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Table Europe Gastric Motility Disorder Drug Sales Volume, by Type (2017-2028)
-
Table Europe Gastric Motility Disorder Drug Sales Volume Share, by Type (2017-2028)
-
Figure Europe Gastric Motility Disorder Drug Sales Volume Share, by Type (2017-2028)
-
Table Europe Gastric Motility Disorder Drug Sales Volume, by Application (2017-2028)
-
Table Europe Gastric Motility Disorder Drug Sales Volume Share, by Application (2017-2028)
-
Figure Europe Gastric Motility Disorder Drug Sales Volume Share, by Application (2017-2028)
-
Figure Germany Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure UK Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure UK Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure France Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure France Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure Italy Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure Spain Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure Poland Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure Russia Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Table APAC Gastric Motility Disorder Drug Sales Volume, by Type (2017-2028)
-
Table APAC Gastric Motility Disorder Drug Sales Volume Share, by Type (2017-2028)
-
Figure APAC Gastric Motility Disorder Drug Sales Volume Share, by Type (2017-2028)
-
Table APAC Gastric Motility Disorder Drug Sales Volume, by Application (2017-2028)
-
Table APAC Gastric Motility Disorder Drug Sales Volume Share, by Application (2017-2028)
-
Figure APAC Gastric Motility Disorder Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure Japan Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure India Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure India Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Gastric Motility Disorder Drug Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Gastric Motility Disorder Drug Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Gastric Motility Disorder Drug Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Gastric Motility Disorder Drug Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Gastric Motility Disorder Drug Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Gastric Motility Disorder Drug Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Gastric Motility Disorder Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Gastric Motility Disorder Drug Sales Value and Growth Rate (2017-2028)
-
Table Concert Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Concert Pharmaceuticals, Inc Product Profiles, Application and Specification
-
Table Concert Pharmaceuticals, Inc Gastric Motility Disorder Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Targacept, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Targacept, Inc Product Profiles, Application and Specification
-
Table Targacept, Inc Gastric Motility Disorder Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table ChironWells GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table ChironWells GmbH Product Profiles, Application and Specification
-
Table ChironWells GmbH Gastric Motility Disorder Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Helsinn Healthcare SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Helsinn Healthcare SA Product Profiles, Application and Specification
-
Table Helsinn Healthcare SA Gastric Motility Disorder Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Theravance, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Theravance, Inc Product Profiles, Application and Specification
-
Table Theravance, Inc Gastric Motility Disorder Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
